Gene Therapy Launch Readiness: Charting a Clear Path to U.S. Commercial Success
18 Sep 2025
Commercializing Gene Therapy in 2025
- Prepare the Market: Strategically mapping and engaging key stakeholders—clinicians, payers, patient advocates—to shape perception, drive demand, and ensure uptake
- Prepare the Organization: Building organizational capabilities and cross functional teams to deliver on the complex demands of gene therapy
- Prepare the Product: Designing a value-driven pricing and reimbursement strategy that aligns with payer expectations, supports sustainable access, and reflects the transformative nature of the therapy
